GPRASP2

GPRASP2 (GASP-2) is a receptor-trafficking and signaling-modulator protein that controls the surface availability and degradative fate of multiple membrane signaling receptors, thereby tuning developmental and synaptic signaling outputs (PMID:24019467, PMID:30926797, PMID:39675768). In the TGF-β branch it acts as an extracellular antagonist of myostatin (MSTN) and GDF-11, blocking ligand binding to the type II receptor; loss of Gasp2 produces axial skeletal transformations, reduced muscle mass, a type IIb-to-IIa fiber shift, and impaired regeneration, while overexpression increases muscle mass and drives a slow-to-fast fiber switch — an activity that is independent of GASP-2 glycosylation (PMID:24019467, PMID:28955860, PMID:31960486). In the Hedgehog pathway, GPRASP2 forms a complex with Pitchfork (Pifo) required for Hedgehog-induced Smoothened translocation to the primary cilium, and it protects SMO from lysosomal degradation to sustain GLI and β-catenin signaling (PMID:26901434, PMID:39675768). In neurons, GPRASP2 governs postendocytic sorting of mGluR5 to bidirectionally set its surface levels, shaping hippocampal mGluR-dependent LTD, dendritic and spine morphology, and behaviour, with loss producing ASD-like phenotypes (PMID:30926797). In the cochlea, GPRASP2 binds NCAM1 and supports Hedgehog signaling to maintain mitochondrial integrity, iron homeostasis, and hair cell survival (PMID:34418635, PMID:41688572). The protein also physically interacts with huntingtin in neuronal cells (PMID:16835690).

1. 2006 Medium

   Established GPRASP2's first physical interaction partner, linking it to neuronal protein networks and GPCR sorting before any functional role was known.

   Evidence Yeast two-hybrid, reciprocal Co-IP, and co-localization with huntingtin in SH-SY5Y cells

   PMID:16835690

   Open questions at the time

   • No functional consequence of the htt interaction demonstrated
   • Whether the interaction influences receptor trafficking untested
2. 2013 High

   Defined GPRASP2 as an extracellular antagonist of myostatin and GDF-11, answering how it acts at the initial step of TGF-β signaling and revealing its in vivo role in muscle and skeletal patterning.

   Evidence Ligand-receptor binding assays and Gasp2 knockout mouse phenotyping (muscle, fiber type, regeneration, skeleton)

   PMID:24019467

   Open questions at the time

   • Structural basis of ligand sequestration not resolved
   • Relationship to its intracellular trafficking roles unclear
3. 2016 High

   Identified the GPRASP2-Pifo complex as required for Hedgehog-induced Smoothened ciliary translocation, placing GPRASP2 in ciliary signal transduction.

   Evidence Co-IP of Pifo-Gprasp2, siRNA/shRNA depletion with Smo ciliary immunofluorescence and Hh target-gene qRT-PCR

   PMID:26901434

   Open questions at the time

   • Direct mechanism of Smo handoff to the cilium unknown
   • Stoichiometry and structure of the Pifo-Gprasp2 complex undefined
4. 2016 Medium

   Showed that GPRASP2 promotes myoblast proliferation and differentiation through myostatin pathway inhibition and that this activity does not require glycosylation, constraining its biochemical mechanism.

   Evidence Overexpression/knockdown in C2C12 myoblasts and inhibitory activity of bacterially expressed deglycosylated recombinant GASP-2

   PMID:28955860

   Open questions at the time

   • Domain mediating myostatin binding not mapped
   • In vitro myoblast result not yet linked to in vivo mechanism
5. 2019 High

   Demonstrated that GPRASP2 controls postendocytic sorting of mGluR5 to bidirectionally set surface receptor levels, establishing a direct role in synaptic plasticity and behaviour.

   Evidence Gprasp2 KO plus overexpression, mGluR5 surface biotinylation, hippocampal LTD electrophysiology, dendritic/spine imaging, behavioural testing

   PMID:30926797

   Open questions at the time

   • Molecular machinery linking GPRASP2 to the sorting decision not defined
   • Whether other GPCRs are co-regulated in neurons untested
6. 2020 Medium

   Resolved why GASP-2 and GASP-1 produce divergent muscle outcomes by showing GASP-2 has lower myostatin affinity, refining the gain-of-function consequence in vivo.

   Evidence Gasp-2 transgenic overexpression mice with muscle mass, fiber-type IHC, TGF-β gene expression, and metabolic phenotyping versus GASP-1 transgenics

   PMID:31960486

   Open questions at the time

   • Quantitative affinity differences not structurally explained
   • Basis for GASP-1-specific myostatin upregulation unresolved
7. 2021 Medium

   Linked GPRASP2 to auditory cell survival through Hedgehog pathway dependence, showing its loss triggers mitochondrial damage and apoptosis rescuable by a Smoothened agonist.

   Evidence CRISPR KO in HEI-OC1 cells, RNA-seq, Hh and apoptosis western blots, flow cytometry, EM, and purmorphamine rescue

   PMID:34418635

   Open questions at the time

   • How GPRASP2 loss lowers Hh signaling mechanistically not shown here
   • Cell-line context may not reflect native hair cells
8. 2024 Medium

   Connected GPRASP2 deficiency to AMPK/DRP1-driven mitochondrial fragmentation in spiral ganglion cells, identifying a specific effector pathway for its protective role.

   Evidence shRNA knockdown in primary SGCs, AMPK/DRP1 western blots, mitochondrial imaging, JC-1, apoptosis flow cytometry, and Mdivi-1 rescue

   PMID:39253164

   Open questions at the time

   • Link between GPRASP2 receptor trafficking and AMPK activation unestablished
   • Direct molecular target of GPRASP2 in SGCs unknown
9. 2024 Medium

   Showed GPRASP2 protects SMO from lysosomal degradation to sustain Hedgehog and β-catenin signaling, driving supporting-cell proliferation and hair-cell regeneration.

   Evidence Cochlear organoid overexpression, SMO lysosomal stability assay, Hh/β-catenin western blots, cell-marker immunofluorescence, and AAV-Gprasp2 with SAG in damaged explants

   PMID:39675768

   Open questions at the time

   • Mechanism by which GPRASP2 shields SMO from lysosomes undefined
   • Whether β-catenin effect is direct or downstream of Hh unclear
10. 2026 Medium

    Identified NCAM1 as a GPRASP2 binding partner whose loss enhances ferritinophagy, tying GPRASP2 to iron homeostasis and hearing in cochlear hair cells.

    Evidence GPRASP2-NCAM1 binding assay, Gprasp2-deficient mice, NCAM1/ferritinophagy western blots, ABR, and cochlear immunofluorescence

    PMID:41688572

    Open questions at the time

    • How GPRASP2-NCAM1 binding controls ferritinophagy mechanistically unknown
    • Single-lab interaction without reciprocal structural validation
11. 2026 Medium

    Extended GPRASP2 function to hematopoietic stem cells, proposing it drives elevated endocytosis to attenuate receptor signaling and maintain quiescence.

    Evidence GPRASP2 fractionation enrichment in HSCs, disruption with endocytosis, signaling, proliferation, and reconstitution assays (preprint)

    PMID:41726907

    Open questions at the time

    • Preprint, not yet peer-reviewed
    • Specific receptors internalized via GPRASP2 in HSCs not identified
    • Direct endocytic machinery interaction unmapped

• How a single protein coordinates extracellular ligand antagonism, ciliary receptor trafficking, postendocytic sorting, and protection of receptors from lysosomal degradation across such diverse tissues remains mechanistically unresolved.
• No structural model defining distinct functional domains
• Unclear whether intracellular sorting and extracellular antagonism are separable activities
• Direct sorting/endocytic machinery partners not identified